Navigation Links
CORD:USE Cord Blood Bank Receives Grant From HRSA to Increase the National Cord Blood Inventory
Date:12/9/2009

ORLANDO, Fla., Dec. 9 /PRNewswire/ -- CORD:USE Cord Blood Bank is proud to announce that the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services has awarded CORD:USE Cord Blood Bank a three-year, multi-million dollar contract to expand the supply of cord blood units for the National Cord Blood Inventory (NCBI).

"Being a NCBI bank is a prestigious designation which further validates the procedures and operations which CORD:USE utilizes to ensure that our cord blood units are of the highest possible quality," said Dr. Edward Guindi, M.D., President and CEO of CORD:USE. "CORD:USE is honored to have assembled a world-class team of pioneers and leaders in the field of cord blood banking and transplantation, and this award is wonderful recognition of CORD:USE Cord Blood Bank, which they have helped build."

The NCBI was created as part of the Stem Cell Therapeutic and Research Act of 2005, Public Law 109-129. The goal of this legislation is to place 150,000 new high quality cord blood units into the NCBI to be made available for public use to potentially save the lives of patients in need of a transplant.

"The funds from this three-year contract with HRSA will be utilized by CORD:USE to add additional high quality, ethnically and racially diverse cord blood units to the NCBI," said Michael Ernst, Executive Vice President and CFO of CORD:USE. "We are thrilled to be employing these resources along with ours to achieve our mission to help many more patients in need."

About CORD:USE

CORD:USE Cord Blood Bank, headquartered in Orlando, Florida is creating a large, ethnically diverse, high quality inventory of available cord blood stem cell units for the many patients in need of a potentially life-saving transplant. CORD:USE has entered into agreements with hospitals across the country to provide mothers the option to donate their babies' cord blood. CORD:USE makes these cord blood units available to transplanters throughout the country and around the world, as a critical component in their patients' treatment. CORD:USE is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) and lists all of its units on the National Marrow Donor Program's Registry. For more information, please visit www.corduse.com.

SOURCE CORD:USE Cord Blood Bank


'/>"/>
SOURCE CORD:USE Cord Blood Bank
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CORD:USE Cord Blood Bank Receives Prestigious Accreditation from the Foundation for the Accreditation of Cellular Therapy
2. Specific antagonism lowers blood pressure
3. Restricting Blood Flow May Help Heart Bypass Patients
4. FDA Updates Prescription Guidelines for Blood Thinner
5. Doctors Often Miss High Blood Pressure in Kids
6. Back to School Means Return of School Blood Drives
7. Blood-flow detector software show promise in preventing brain damage
8. FDA Approves New Roche West Nile Virus Blood Screening Test
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. Laser blasts viruses in blood
11. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... and clinical outcomes, today released the podcast, “Make Plans for MACRA,” ... value-based payment into the physician's office and how physicians and other clinicians are ...
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, president ... honored by Enterprising Women magazine as one of its 2017 Enterprising Women of ... owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively support ...
(Date:4/26/2017)... JOHYNSTON, Iowa (PRWEB) , ... April 26, 2017 ... ... agriculture? DuPont Pioneer today launched a unique website ( CRISPRCas.pioneer.com ) that demonstrates ... plants and help farmers produce more and better food, with fewer resources. It ...
(Date:4/25/2017)... San Jose, CA (PRWEB) , ... April 25, ... ... in cross-screen access, support, and collaboration, announces Mirroring360 Pro . This new ... providing a comprehensive collaboration experience for education and business. , Mirroring360 Pro enables ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
Breaking Medicine Technology: